Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ESPR
#2602
Esperion Therapeutics, Inc. - Common Stock
3.1
8
USD
0.00%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-0.31%
Monthly Change
+0.63%
6 month change
-18.67%
Year Change
+169.49%
Previous Close
3.1
9
Open
3.1
8
Low
3.1
8
High
3.1
8
Volume
212
Markets
US Stock Market
Healthcare
Drug Manufacturers—Specialty & Generic
ESPR
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
27.94 M
62.82 M
76.57 M
185.05 M
197.85 M
256.81 M
257.43 M
Valuation ratios
Enterprise value
600.91 M
363.5 M
582.31 M
719.7 M
582.8 M
1.03 B
913.83 M
Price to earnings ratio
—
-0.54
-1.66
-1.44
-7.86
-33.64
—
Price to sales ratio
—
1.84
5.14
2.59
1.24
1.91
1.61
Price to cash flow ratio
—
-0.55
2.22
2.22
17.41
-58.74
-43.6
Price to book ratio
—
-0.73
1.2
0.66
1.06
-2.55
-0.45
Enterprise value to EBITDA ratio
-5.04
-1.62
-3.28
-4.67
10.41
16.28
11.6
Profitability ratios
Return on assets %
-0.41
-0.71
-0.94
-1.02
-0.15
-0.05
-0.05
Return on equity %
1.49
1.37
0.72
0.46
0.13
0.08
0.08
Return on invested capital %
-4 269.25
-2 581.17
-1 662.85
-1 112.74
160.63
118.13
-11.77
Gross margin %
100
100
100
100
100
100
100
Operating margin %
-53.35
-289.02
-237.83
-133.72
16.37
14.95
-8.22
EBITDA margin %
-52.39
-286.19
-235.39
-132.48
16.84
15.72
-7.45
Net margin %
-63.09
-343.04
-309.58
-179.87
-15.57
-5.63
-31.45
Liquidity ratios
Quick ratio
3.51
4.02
2.29
0.87
0.99
1.19
1.18
Current ratio
3.68
4.48
2.67
1.29
1.37
1.54
1.53
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.8
0.21
0.24
0.51
1.21
0.87
0.17
Solvency ratios
Debt to assets ratio
0.51
0.68
1.05
1.27
0.85
0.54
0.54
Debt to equity ratio
-1.87
-1.31
-0.8
-0.57
-0.75
-0.83
-0.81
Long term debt to total assets ratio
0.51
0.68
1.05
1.27
0.85
0.54
0.54
Long term debt to total equity ratio
-1.87
-1.31
-0.8
-0.57
-0.75
-0.83
-0.81
Per share metrics
Operating cash flow per share
—
-9.13
-2.63
-1.31
-0.13
-0.06
-0.07
EBIT per share
—
-7.84
-2.7
-1.51
0.29
0.29
0.37
EBITDA per share
—
-7.77
-2.68
-1.49
0.3
0.3
0.38
Total debt per share
—
8.94
3.91
2.54
1.56
1.2
0.99
Cash per share
—
8.97
2.51
0.8
0.77
0.81
0.62
Net current asset value per share
—
11.38
3.71
1.95
1.81
2.23
1.83
Tangible book value per share
—
-6.81
-4.88
-4.41
-2.08
-1.45
-1.23
Working capital per share
—
8.84
2.32
0.43
0.49
0.78
0.63
Book value per share
—
-6.81
-4.88
-4.41
-2.08
-1.45
-1.23
News
Why Is Altimmune (ALT) Down 11.3% Since Last Earnings Report?
Catalyst (CPRX) Up 0.6% Since Last Earnings Report: Can It Continue?
Epilogue On Esperion Therapeutics Stock (NASDAQ:ESPR)
ESPR Stock Surges 44% in a Month: Here's What You Need to Know
Esperion Therapeutics (ESPR) Down 10% Since Last Earnings Report: Can It Rebound?
Karyopharm Therapeutics (KPTI) Stock Jumps 6.9%: Will It Continue to Soar?
BofA reiterates Esperion Therapeutics stock Underperform rating
Bempedoic acid gains top-level guideline recommendations for cholesterol
Citizens raises Esperion Therapeutics price target on drug growth
ESPR's Q4 Earnings Lag Estimates, Revenues Beat, Stock Down
H.C. Wainwright reiterates Buy on Esperion stock, $16 target
Esperion Q4 2025 slides: 38% sales growth, $4.6B CHF opportunity